| Antigen: |
Poliovirus type 2 |
| Clone: |
267, 1037, 1050, 697, 1233 |
| Subclass: |
IgG3: 267, 697
IgG2a: 1037, 1050
IgM: 1233
|
| Applications: |
In vitro potency assays of inactivated poliovaccines (1037, 1050) Intertypic differentiation of poliovirus strains in neutralisation assays (697, 1233)
Assays of the virus content of trivalent oral poliovaccines (267)
Serotyping polioviruses by direct immunofluorescence (267)
|
| Immunogen: |
Poliovirus 2 Sabin vaccine virus (clones 267, 697)
Trypsin treated poliovirus 2 Sabin vaccine virus (1037, 1050, 1233) |
| Reactivity: |
Poliovirus |
| Species raised in: |
Mouse: Balb/C |
| Fusion partner: |
P3.X63-Ag8 (for clone 267)
NSO (for clones 1037, 1050, 697, 1233) |
| Recommended growth conditions: |
RPMI 1640
10% FCS
0.3% L-glutamine
1 x hypoxanthine-thymidine |
| References: |
- |
| Notes: |
All clones are broadly reactive with type 2 poliovirus strains except clone 1233 which reacts only with virus strains derived from type 2 Sabin vaccine virus |
For further information about antibodies from CRT or to discuss sales or licensing options, please contact us at reagents@cancertechnology.com
Click here to view Notes and Disclaimer information |
